New flu vaccine shows promise in large trial

NCT ID NCT05569239

Ongoing ⭐️ VACCINE ⭐️ Sponsor: Osivax Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a single dose of a new flu vaccine called OVX836 in about 2,850 healthy adults aged 18 to 59. The goal is to see if it can prevent confirmed influenza A and how safe it is. Participants will be randomly assigned to receive either the vaccine or a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

influenza prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLUENZA

Contacts and locations

Locations

FI-14

Kokkola, Finland
Site BE-01

Ghent, Belgium
Site BE-02

Antwerp, Belgium
Site BE-03

Antwerp, Belgium
Site BE-04

Mechelen, Belgium
Site DE-16

München, Germany
Site FI-08

Helsinki, Finland
Site FI-09

Tampere, Finland
Site FI-10

Turku, Finland
Site FI-11

Oulu, Finland
Site FI-12

Espoo, Finland
Site FI-13

Jarvenpaa, Finland
Site FI-15

Seinäjoki, Finland
Site FR-05

Lyon, France
Site FR-06

Rennes, France
Site FR-07

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.